Goldman Sachs
ISRG icon

Goldman Sachs’s Intuitive Surgical ISRG Stock Holding History

Goldman Sachs’s Portfolio ISRG Stock Details ISRG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.13B Buy
2,451,269
+33,473
+1% +$16.9M 0.13% 138
2025
Q4 		$1.37B Sell
2,417,796
-719,903
-23% -$383M 0.17% 101
2025
Q3 		$1.4B Buy
3,137,699
+568,261
+22% +$273M 0.17% 98
2025
Q2 		$1.4B Sell
2,569,438
-181,228
-7% -$94.8M 0.19% 87
2025
Q1 		$1.36B Buy
2,750,666
+510,375
+23% +$282M 0.22% 73
2024
Q4 		$1.17B Sell
2,240,291
-148,220
-6% -$77.2M 0.18% 88
2024
Q3 		$1.17B Buy
2,388,511
+28,115
+1% +$13.1M 0.19% 89
2024
Q2 		$1.05B Buy
2,360,396
+220,942
+10% +$88M 0.18% 97
2024
Q1 		$854M Sell
2,139,454
-481,387
-18% -$182M 0.15% 128
2023
Q4 		$884M Buy
2,620,841
+388,391
+17% +$116M 0.16% 112
2023
Q3 		$653M Buy
2,232,450
+178,148
+9% +$55.6M 0.14% 132
2023
Q2 		$702M Buy
2,054,302
+14,574
+0.7% +$4.41M 0.15% 119
2023
Q1 		$521M Sell
2,039,728
-318,083
-13% -$78.4M 0.12% 156
2022
Q4 		$626M Buy
2,357,811
+179,073
+8% +$43.7M 0.15% 117
2022
Q3 		$408M Buy
2,178,738
+290,510
+15% +$62.4M 0.1% 166
2022
Q2 		$379M Buy
1,888,228
+621,063
+49% +$146M 0.09% 172
2022
Q1 		$382M Buy
1,267,165
+165,218
+15% +$48.3M 0.08% 230
2021
Q4 		$396M Buy
1,101,947
+23,792
+2% +$8.19M 0.08% 245
2021
Q3 		$357M Sell
1,078,155
-9,276
-0.9% -$3.11M 0.08% 238
2021
Q2 		$333M Buy
1,087,431
+79,818
+8% +$22.4M 0.07% 247
2021
Q1 		$248M Buy
1,007,613
+120,453
+14% +$30.3M 0.06% 310
2020
Q4 		$242M Sell
887,160
-460,158
-34% -$114M 0.06% 283
2020
Q3 		$319M Buy
1,347,318
+226,227
+20% +$50.8M 0.09% 197
2020
Q2 		$213M Sell
1,121,091
-313,926
-22% -$56.3M 0.06% 293
2020
Q1 		$237M Sell
1,435,017
-514,704
-26% -$94.3M 0.08% 223
2019
Q4 		$384M Buy
1,949,721
+170,268
+10% +$31.9M 0.1% 208
2019
Q3 		$320M Buy
1,779,453
+220,812
+14% +$38.2M 0.09% 213
2019
Q2 		$273M Buy
1,558,641
+104,394
+7% +$17.9M 0.08% 256
2019
Q1 		$277M Sell
1,454,247
-99,057
-6% -$17.6M 0.08% 234
2018
Q4 		$248M Sell
1,553,304
-169,686
-10% -$28.8M 0.08% 249
2018
Q3 		$330M Buy
1,722,990
+10,629
+0.6% +$1.89M 0.09% 233
2018
Q2 		$273M Sell
1,712,361
-871,263
-34% -$133M 0.07% 267
2018
Q1 		$356M Buy
2,583,624
+87,024
+3% +$12.1M 0.09% 235
2017
Q4 		$304M Sell
2,496,600
-3,182,697
-56% -$398M 0.07% 292
2017
Q3 		$660M Sell
5,679,297
-1,973,376
-26% -$215M 0.16% 96
2017
Q2 		$795M Sell
7,652,673
-4,401,117
-37% -$423M 0.21% 66
2017
Q1 		$1.03B Buy
12,053,790
+9,538,236
+379% +$753M 0.28% 45
2016
Q4 		$177M Buy
2,515,554
+318,942
+15% +$23.4M 0.05% 446
2016
Q3 		$177M Buy
2,196,612
+916,920
+72% +$70.2M 0.05% 405
2016
Q2 		$94M Buy
1,279,692
+94,734
+8% +$6.67M 0.03% 707
2016
Q1 		$79.1M Sell
1,184,958
-127,737
-10% -$7.92M 0.03% 794
2015
Q4 		$79.7M Sell
1,312,695
-1,419,741
-52% -$79.7M 0.03% 799
2015
Q3 		$140M Buy
2,732,436
+141,696
+5% +$8.03M 0.05% 454
2015
Q2 		$139M Buy
2,590,740
+68,112
+3% +$3.81M 0.04% 488
2015
Q1 		$142M Buy
2,522,628
+242,856
+11% +$13.7M 0.05% 493
2014
Q4 		$134M Buy
2,279,772
+334,503
+17% +$18.6M 0.04% 536
2014
Q3 		$99.8M Sell
1,945,269
-4,209,651
-68% -$209M 0.03% 644
2014
Q2 		$282M Buy
6,154,920
+4,975,146
+422% +$219M 0.09% 243
2014
Q1 		$57.4M Sell
1,179,774
-415,260
-26% -$19.6M 0.02% 958
2013
Q4 		$68.1M Sell
1,595,034
-441,342
-22% -$18.6M 0.02% 851
2013
Q3 		$85.1M Buy
2,036,376
+1,251,531
+159% +$55.3M 0.03% 657
2013
Q2 		$44.1M Buy
+784,845
New +$43.2M 0.02% 980

Other funds holding ISRG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Goldman Sachs's ISRG Position: Q1 2026 in Review

Goldman Sachs increased its Intuitive Surgical (ISRG) stake by 1.4% in Q1 2026, buying an estimated $16.9M and bringing the position to 2,451,269 shares worth $1.13B. The position accounts for 0.13% of the portfolio, ranked #138.

Goldman Sachs first reported a position in ISRG in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.4B in Q3 2025. 2,302 funds tracked by Wall St. Rank hold ISRG as of Q1 2026.

  • Goldman Sachs held 2,451,269 shares of Intuitive Surgical worth $1.13B as of Q1 2026.
  • Goldman Sachs bought 33,473 Intuitive Surgical shares in Q1 2026, an estimated $16.9M.
  • Intuitive Surgical made up 0.13% of Goldman Sachs's portfolio in Q1 2026, its #138 holding.
  • Goldman Sachs first reported a position in Intuitive Surgical in Q2 2013 and has held it in 52 quarters since.
  • Goldman Sachs's Intuitive Surgical position peaked at $1.4B in Q3 2025.
  • 2,302 funds tracked by Wall St. Rank held Intuitive Surgical as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.